OLYMAVUS
Live / Allowed — Published for opposition (as of 21 Jul 2026)
What this means for you
Approved and waiting on proof of use. It will register unless the applicant drops it, and its 19 Jan 2026 filing date already counts against anyone who files later.
Record
- Serial number
- 79444400
- Mark type
- Stylized text
- Filed
- 19 Jan 2026
- Published for opposition
- 21 Jul 2026
- Attorney of record
- Kisuk Lee
Goods and services
- Class 005 — Pharmaceuticals: antibodies for medical purposes; pharmaceutical preparations for the treatment of multiple sclerosis; pharmaceutical preparations for the treatment of autoimmune disorders; pharmaceutical preparations for the treatment of central nervous system (CNS) diseases; pharmaceutical preparations for the treatment of inflammatory diseases
Owner
- CELLTRION, INC., KR
- CELLTRION, INC., KR
Prosecution history
- 08 Sept 2026 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 08 Sept 2026 — REGISTERED-PRINCIPAL REGISTER
- 21 Jul 2026 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 21 Jul 2026 — PUBLISHED FOR OPPOSITION
- 15 Jul 2026 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 22 Jun 2026 — NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
- 22 Jun 2026 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 22 Jun 2026 — EXAMINER'S AMENDMENT ENTERED
- 22 Jun 2026 — EXAMINERS AMENDMENT E-MAILED
- 22 Jun 2026 — EXAMINERS AMENDMENT -WRITTEN
- 08 Jun 2026 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 08 Jun 2026 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 08 Jun 2026 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 08 Jun 2026 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 08 Jun 2026 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED